Cargando…
Tetramethylpyrazine protects retinal ganglion cells against H(2)O(2)-induced damage via the microRNA-182/mitochondrial pathway
Glaucoma is the leading cause of irreversible blindness worldwide; the apoptosis of the retinal ganglion cells (RGCs) is a hallmark of glaucoma. Tetramethylpyrazine (TMP) is the main active component of Ligusticum wallichii Franchat, and has been demonstrated to improve a variety of injuries through...
Autores principales: | Li, Xinmin, Wang, Qiuli, Ren, Yanfan, Wang, Xiaomin, Cheng, Huaxu, Yang, Hua, Wang, Baojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605642/ https://www.ncbi.nlm.nih.gov/pubmed/31173163 http://dx.doi.org/10.3892/ijmm.2019.4214 |
Ejemplares similares
-
Targeted deletion of miR-182, an abundant retinal microRNA
por: Jin, Zi-Bing, et al.
Publicado: (2009) -
Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018) -
MicroRNA-183/96/182 cluster in immunity and autoimmunity
por: Wang, Zhuang, et al.
Publicado: (2023) -
Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016) -
Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2015)